TAUG Stock Overview
Tauriga Sciences, Inc. produces and sells cannabidiol infused chewing gum under the Tauri-Gum brand name.
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 0/6 |
| Dividends | 0/6 |
Tauriga Sciences, Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$0.000001 |
| 52 Week High | US$0.00001 |
| 52 Week Low | US$0.000001 |
| Beta | 0 |
| 1 Month Change | 0% |
| 3 Month Change | 0% |
| 1 Year Change | 0% |
| 3 Year Change | -100.00% |
| 5 Year Change | -100.00% |
| Change since IPO | -100.00% |
Recent News & Updates
Recent updates
Shareholder Returns
| TAUG | US Pharmaceuticals | US Market | |
|---|---|---|---|
| 7D | 0% | -2.2% | -3.7% |
| 1Y | 0% | 11.6% | 20.5% |
Return vs Industry: TAUG underperformed the US Pharmaceuticals industry which returned 11.7% over the past year.
Return vs Market: TAUG underperformed the US Market which returned 20.2% over the past year.
Price Volatility
| TAUG volatility | |
|---|---|
| TAUG Average Weekly Movement | n/a |
| Pharmaceuticals Industry Average Movement | 9.6% |
| Market Average Movement | 6.0% |
| 10% most volatile stocks in US Market | 16.4% |
| 10% least volatile stocks in US Market | 3.0% |
Stable Share Price: TAUG has not had significant price volatility in the past 3 months.
Volatility Over Time: Insufficient data to determine TAUG's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2001 | n/a | Seth Shaw | www.tauriga.com |
Tauriga Sciences, Inc. produces and sells cannabidiol infused chewing gum under the Tauri-Gum brand name. It also develops anti-nausea products; and skin care products include CBD facemasks; CBD daily moisturizer; CBD anti-wrinkle dream, hand, and foot cream with hemp seed oil; CBD massage and body oil; CBD body revive roll-on; CBD transdermal patch; and CBD body spray. In addition, the company offers rainbow deluxe sampler pack, CBD non-GMO dietary supplements, and CBD scented bath bombs.
Tauriga Sciences, Inc. Fundamentals Summary
| TAUG fundamental statistics | |
|---|---|
| Market cap | US$348.00 |
| Earnings (TTM) | -US$6.13m |
| Revenue (TTM) | US$313.50k |
0.0x
P/S Ratio0.0x
P/E RatioIs TAUG overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| TAUG income statement (TTM) | |
|---|---|
| Revenue | US$313.50k |
| Cost of Revenue | US$154.24k |
| Gross Profit | US$159.26k |
| Other Expenses | US$6.29m |
| Earnings | -US$6.13m |
Last Reported Earnings
Dec 31, 2021
Next Earnings Date
n/a
| Earnings per share (EPS) | 0 |
| Gross Margin | 0.00% |
| Net Profit Margin | 0.00% |
| Debt/Equity Ratio | 0.0% |
How did TAUG perform over the long term?
See historical performance and comparison